Literature DB >> 146727

A potassium ionophore (Nigericin) inhibits stimulation of human lymphocytes by mitogens.

R P Daniele, S K Holian, P C Nowell.   

Abstract

Nigericin, an ionophore that exchanges K+ for H+ across most biologic membranes, reversibly inhibited the proliferative response of human lymphocytes to phytohemagglutinin (PHA). Inhibition occurred at nigericin concentrations of 10(-8) M or greater, and only during the early event of mitogenesis. There was no effect if nigericin was added 24 h or later after the initiation of PHA-stimulated cultures. The effect was not the result of toxicity or impaired mitochondrial respiration. At similar concentrations, nigericin also inhibited lymphocyte responses in mixed lymphocyte cultures and to other mitogens including concanavalin A, pokeweed mitogen, and the calcium ionophore A23187. The findings support the view that one or more transmembranous events, mediated by changes in cation flux and/or membrane potential, are critical in the initial stages of lymphocyte mitogenesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 146727      PMCID: PMC2184504          DOI: 10.1084/jem.147.2.571

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  The specific and endogenous mitotic inhibitor of lymphocytes (chalone).

Authors:  A M Attallah; G H Sunshine; C V Hunt; J C Houck
Journal:  Exp Cell Res       Date:  1975-07       Impact factor: 3.905

2.  Effects of mitogens on sodium-potassium transport, 3H-ouabain binding, and adenosine triphosphatase activity in lymphocytes.

Authors:  R Averdunk; P K Lauf
Journal:  Exp Cell Res       Date:  1975-07       Impact factor: 3.905

3.  Assay of picomole amounts of ATP, ADP, and AMP using the luciferase enzyme system.

Authors:  G A Kimmich; J Randles; J S Brand
Journal:  Anal Biochem       Date:  1975-11       Impact factor: 3.365

4.  Two biological activities regulating cell proliferation found in cultures of peritoneal exudate cells.

Authors:  J Calderon; E R Unanue
Journal:  Nature       Date:  1975-01-31       Impact factor: 49.962

5.  Isolation of a divalent cation ionophore from beef heart mitochondria.

Authors:  G A Blondin
Journal:  Biochem Biophys Res Commun       Date:  1974-01       Impact factor: 3.575

6.  The role of calcium ions in initiating transformation of lymphocytes.

Authors:  V C Maino; N M Green; M J Crumpton
Journal:  Nature       Date:  1974-09-27       Impact factor: 49.962

7.  Lymphocyte monovalent cation metabolism: cell volume, cation content and cation transport.

Authors:  M A Lichtman; A H Jackson; W A Peck
Journal:  J Cell Physiol       Date:  1972-12       Impact factor: 6.384

8.  Production by stimulated macrophages of factors depressing lymphocyte transformation.

Authors:  D S Nelson
Journal:  Nature       Date:  1973-11-30       Impact factor: 49.962

9.  Ionophorous activity and murine B lymphocyte mitogens.

Authors:  D L Rosenstreich; R Blumenthal
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

10.  A potassium ionophore (valinomycin) inhibits lymphocyte proliferation by its effects on the cell membrane.

Authors:  R P Daniele; S K Holian
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

View more
  3 in total

1.  Membrane potential changes during mitogenic stimulation of mouse spleen lymphocytes.

Authors:  H Kiefer; A J Blume; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

2.  Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis.

Authors:  Xin Chen; Wan-Ting He; Lichen Hu; Jingxian Li; Yuan Fang; Xin Wang; Xiaozheng Xu; Zhuo Wang; Kai Huang; Jiahuai Han
Journal:  Cell Res       Date:  2016-08-30       Impact factor: 25.617

3.  Nigericin is a potent inhibitor of the early stage of vaccinia virus replication.

Authors:  Chad Myskiw; Jessica Piper; Rhiannon Huzarewich; Tim F Booth; Jingxin Cao; Runtao He
Journal:  Antiviral Res       Date:  2010-10-15       Impact factor: 10.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.